Product image of Naloxona Kern Pharma (Naloxone Hydrochloride) supplied by GNH India

Naloxona Kern Pharma

Active Ingredient:
Naloxone Hydrochloride
Origin:
EU

Naloxona Kern Pharma (Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxona Kern Pharma, is an opioid antagonist presented as a sterile injectable solution for intramuscular and intravenous use. It rapidly reverses opioid‑induced respiratory depression and sedation in emergency situations.

GNH India supplies Naloxona Kern Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Kern Pharma, S.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Naloxone is an opioid antagonist used in the management of acute opioid toxicity and related respiratory compromise.

  • Opioid overdose: restores normal respiration and consciousness in patients with life‑threatening opioid intoxication.
  • Opioid‑induced respiratory depression: rapidly reverses breathing suppression caused by opioid analgesics.
  • Opioid toxicity in emergency settings: prevents fatal outcomes by antagonising mu‑opioid receptors.

How It Works

  • Naloxone acts as a competitive antagonist at opioid receptors, primarily the mu subtype. By binding to these receptors without activating them, it displaces opioid agonists and blocks their pharmacologic effects, quickly reversing respiratory depression, sedation, and hypotension associated with opioid exposure.

Side Effects

Naloxone is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Injection site pain or irritation
  • Nausea or vomiting
  • Sweating or diaphoresis
  • Headache
  • Dizziness or light‑headedness
  • Flushing

Serious or Rare Side Effects

  • Severe hypotension or cardiovascular collapse
  • Pulmonary edema
  • Anaphylactic or severe allergic reaction
  • Seizures
  • Cardiac arrest
  • Acute withdrawal syndrome in opioid‑dependent patients

Precautions & Warnings

Naloxone should be used with careful clinical assessment and monitoring.

  • Assess opioid exposure: confirm recent opioid use before administration.
  • Monitor respiratory status: observe breathing and oxygen saturation continuously after dosing.
  • Hypersensitivity: avoid in patients with known allergy to naloxone or formulation components.
  • Cardiovascular disease: use cautiously in patients with unstable heart conditions.
  • Pediatric and elderly patients: adjust monitoring intensity due to variable response.
  • Store at ambient temperature: keep in original packaging, protect from moisture and light.

Avoid Interactions

Naloxone may interact with other drugs that affect opioid pathways or central nervous system function.

Major Interactions (Avoid)

  • Concurrent use of other opioid antagonists may diminish therapeutic effect.
  • Administration with mixed agonist‑antagonist opioids (e.g., buprenorphine) can precipitate severe withdrawal.
  • High‑dose vasopressors may mask hemodynamic changes after naloxone.

Moderate Interactions (Monitor Closely)

  • Benzodiazepines or other CNS depressants can obscure assessment of naloxone efficacy.
  • Monoamine oxidase inhibitors may alter metabolism of co‑administered opioids, affecting reversal dynamics.
  • Certain antihypertensive agents may exacerbate hypotension after rapid opioid reversal.

Frequently Asked Questions

Naloxona Kern Pharma contains naloxone hydrochloride, an opioid antagonist used to rapidly reverse the effects of opioid overdose, including life‑threatening respiratory depression and excessive sedation, in emergency medical settings.

Naloxone competitively binds to mu‑opioid receptors without activating them, displacing opioid molecules and blocking their effects. This restores normal respiratory drive and consciousness by eliminating the pharmacologic action of the opioid.

The specific dose and administration schedule are determined by the prescribing clinician based on the patient’s condition, the route of administration, and local treatment protocols. Healthcare professionals should follow established guidelines and product labeling.

Safety data for naloxone in pregnancy and lactation are limited. It is generally considered when the benefits of reversing a life‑threatening opioid overdose outweigh potential risks. Clinicians should evaluate each case individually and consult relevant obstetric guidance.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Naloxona Kern Pharma delivers naloxone, the standard opioid antagonist with rapid onset and short duration of action, making it suitable for emergency reversal. Compared with longer‑acting agents such as nalmefene, naloxone requires repeat dosing but provides quicker symptom resolution.

Store the product at ambient temperature, below 25 °C, in its original container. Protect it from moisture, direct sunlight, and extreme temperatures. Do not freeze the solution, and keep the vial sealed until use.

Naloxona Kern Pharma is supplied as a sterile injectable solution for intramuscular or intravenous injection. Administration is performed by qualified healthcare personnel, typically using a rapid bolus dose followed by observation and additional dosing if needed.

Serious risks include acute opioid withdrawal, especially in opioid‑dependent individuals, severe hypotension, cardiac arrhythmias, pulmonary edema, and rare anaphylactic reactions. Immediate medical monitoring is essential after administration.

Patients with known hypersensitivity to naloxone or any component of the formulation should not receive the product. Caution is advised in individuals with unstable cardiovascular disease, severe hypertension, or those receiving mixed agonist‑antagonist opioids, where withdrawal may be precipitated.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Naloxone Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT